# Arthrosurface

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arthrosurface

- Industry: Medical Devices & Equipment
- Headquarters: Franklin, US
- Website: www.arthrosurface.com
- Total disclosed funding: $31M
- Latest round: Series F (Feb 29, 2008)
- Investors on record: 1

## About

Arthrosurface, Inc. specializes in innovative joint replacement solutions, offering minimally invasive products that improve patient mobility and quality of life across various joints, including the knee, shoulder, wrist, and ankle.Founded in 2001, Arthrosurface, Inc. is based in Franklin, US, focusing on motion-preserving joint replacement solutions. The company has engaged in 6 deals, with the most recent deal dated January 6, 2020, involving an Add-on Trade Sale led by Anika Therapeutics, raising USD 60.00 mn. The CEO, Joe Darling, leads the company, while the company has not undergone significant strategic pivots since its founding.Arthrosurface specializes in motion-preserving joint replacement solutions primarily through its minimally invasive joint replacement products designed for a variety of joints, including the knee, shoulder, wrist, and ankle. These products focus on enhancing patients' quality of life by restoring mobility, reducing pain, and minimizing recovery time compared to traditional total joint replacement options. Arthrosurface's offerings include innovative implants that allow for greater range of motion and are tailored for active patients who seek to maintain their lifestyle following joint surgery. The company serves a diverse clientele, including healthcare providers, orthopedic surgeons, and patients across the United States, particularly in metropolitan areas and regions with a high demand for advanced orthopedic solutions.Arthrosurface generates revenue primarily through the sale of its proprietary joint replacement products to medical professionals and healthcare facilities. The business model focuses on direct sales to orthopedic surgeons and hospitals, facilitating the adoption of their innovative implants in surgical practices. Transactions typically involve the purchase of individual implants or bulk orders for medical institutions, with potential for partnerships and contracts with healthcare providers to ensure ongoing supply. Pricing structures may vary based on the specific product lines, including flagship offerings tailored for upper extremity applications. The company’s established network of trained physicians and their emphasis on clinical outcomes drives demand for their solutions, positioning them favorably within the orthopedic market.Following the acquisition by Anika Therapeutics in January 2020 for USD 60.00 mn, Arthrosurface plans to leverage this funding to support the development of new products aimed at enhancing joint function and mobility. The company is targeting expansion into new regions, particularly in the southeastern US, with plans to establish a presence by 2025. This growth strategy is designed to meet increasing demand for joint replacement solutions.

## Funding rounds

- Series F, Feb 29, 2008, $4M — Boston Millennia Partners
- Series E, Aug 1, 2006, $5M — Boston Millennia Partners
- Series D, Feb 10, 2005, $11M — Boston Millennia Partners
- Series C, Mar 25, 2004, $6M — Boston Millennia Partners
- Series A, Sep 5, 2003, $5.3M — Boston Millennia Partners

## Investors

- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Series A, Series C, Series D, Series E, Series F